The effect of 2000 ıu/day vitamin D supplementation on insulin resistance and cardiovascular risk parameters in vitamin D deficient obese adolescents

The effect of 2000 ıu/day vitamin D supplementation on insulin resistance and cardiovascular risk parameters in vitamin D deficient obese adolescents

The aim of this study was to determine the vitamin D deficiency prevalence inobese adolescents and to investigate the effect of vitamin D supplementationon insulin resistance and cardiovascular risk parameters in obese adolescentswith vitamin D deficiency. Ninety-six obese adolescents aged 10-18 years weredivided in 2 groups according to their vitamin D levels: Deficient group (

___

  • 1. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
  • 2. Rajakumar K, Fernstrom JD, Holick MF, Janosky JE, Greenspan SL. Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children. Obesity (Silver Spring) 2008; 16: 90-95.
  • 3. Caron- Jobin M, Morissett AS, Tremblay A, Huot C, Légaré D, Tchernof A. Elevated serum 25 (OH) D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity (Silver Spring) 2011; 19: 1335-1341.
  • 4. Newton AL, Hanks LJ, Ashraf AP, Williams E, Davis M, Casazza K. Macronutrient intake influences the effect of 25hydroxy-vitamin d status on metabolic syndrome outcomes in african american girls. Cholesterol 2012; 2012: 581432.
  • 5. Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, Ten S. Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab 2007; 20: 817-823.
  • 6. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J.Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004; 89-90: 387-392.
  • 7. Andıran N, Çelik N, Akça H, Doğan G. Vitamin D deficiency in children and adolescents. J Clin Res Pediatr Endocrinol 2012; 4: 25-29.
  • 8. Javed A, Vella A, Balagopal PB, et al. Cholecalciferol supplementation does not influence β-cell function and insulin action in obese adolescents: a prospective double-blind randomized trial. J Nutr 2015; 145: 284-290.
  • 9. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209: 823-825.
  • 10. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
  • 11. de Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54: 945-955.
  • 12. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
  • 13. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O. Body mass index references for Turkish children. Acta Paediatr 2006; 95: 194-198.
  • 14. Hatipoglu N, Ozturk A, Mazicioglu MM, Kurtoglu S, Seyhan S, Lokoglu F. Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents. Eur J Pediatr 2007; 167: 383-389.
  • 15. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114(Suppl 2): 555-576.
  • 16. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51: 170-179.
  • 17. Kurtoglu S, Hatipoglu N, Mazıcıoglu M, Kendirci M, Keskin M, Kondolot M. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2010; 2: 100-106.
  • 18. Zimmet P, Alberti KG, Kaufman F, et al; IDF Consensus Group. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007; 8: 299-306.
  • 19. Munns CF, Shaw N, Kiely M, et al. Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab 2016; 101: 394-415.
  • 20. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington (DC): National Academies Press (US); 1997.
  • 21. Torun E, Gönüllü E, Ozgen IT, Cindemir E, Oktem F. Vitamin D deficiency and insufficiency in obese children and adolescents and its relationship with insulin resistance. Int J Endocrinol 2013; 2013: 631845.
  • 22. Olson ML, Maalouf NM, Oden JD, White PC, Hutchison MR. Vitamin D deficiency in obese children and its relationship to glucose homeostasis. J Clin Endocrinol Metab 2012; 97: 279-285.
  • 23. George L, Bacha F, Lee S, Tfayli H, Andreatta E, Arslanian S. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab 2011; 96: 2136-2145.
  • 24. Levy-Marchal C, Arslanian S, Cutfield W, et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 2010; 95: 5189-5198.
  • 25. Bacha F, Lee S, Gungor N, Arslanian SA. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care 2010; 33: 2225-2231.
  • 26. Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity-assessment, treatment, and prevention: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017;102: 709-757.
  • 27. Belenchia AM, Tosh AK, Hillman LS, Peterson CA. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 2013; 97: 774-781.
  • 28. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes 2000; 49: 1042-1048.
  • 29. Viner RM, Segal TY, Lichtarowicyz- Kyrnska E, Hidmarsh P. Prevalence of insulin resistance syndome in obesity. Arch Dis Child 2005; 90: 10-14.
  • 30. Nader NS, Aguirre Castaneda R, Wallace J, Singh R, Weaver A, Kumar S. Effect of vitamin D3 supplementation on serum 25(OH)D, lipids and markers of insulin resistance in obese adolescents: a prospective, randomized, placebo-controlled pilot trial. Horm Res Paediatr 2014; 82: 107-112.
  • 31. Miraglia del Giudice E, Grandone A, Cirillo G, et al. Bioavailable Vitamin D in obese children: the role of insulin resistance. J Clin Endocrinol Metab 2015; 100: 3949-3955.
  • 32. Cizmecioğlu FM, Etiler N, Görmüş U, Hamzaoğlu O,Hatun S. Hypovitaminosis D in obese and overweight school children. J Clin Res Pediatr Endocrinol 2008; 1: 89-96.
  • 33. Atabek ME, Pirgon O, Kurtoglu S. Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diabetes Res Clin Pract 2006; 72: 315- 321.
  • 34. Bereket, A, Atay Z. Current status of childhood obesity and its associated morbidities in Turkey. J Clin Res Pediatr Endocrinol 2012; 4: 1-7.
  • 35. Roth CL, Elfers C, Kratz M, Hoofnagle AN. Vitamin D deficiency in obese children and its relationship to insulin resistance and adipokines. J Obes 2011; 2011: 495101.
  • 36. Pilz S, Gaksch M, Kienreich K, et al. Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension 2015; 65: 1195-1201.
  • 37. Arora P, Song Y, Dusek J,et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation 2015; 131: 254-262.
  • 38. Rodríguez-Rodríguez E, Aparicio A, Andrés P, Ortega RM. Moderate vitamin D deficiency and inflammation related markers in overweight/obese schoolchildren. Int J Vitam Nutr Res 2014; 84: 98-107.
  • 39. Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E. Effects of a 1-year supplementation 374 with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in 375 overweight and obese subjects. Cytokine 2012; 60: 870-874.
Turkish Journal of Pediatrics-Cover
  • ISSN: 0041-4301
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1958
  • Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler

An infant with intradural extramedullary synovial sarcoma: the youngest case in the literature

Elif İnanç Gürer, Kamil Karaali, Gülen Tüysüz, Alphan Küpesiz, Koray Yalçın, Elif Güler, Saim Kazan

Letter to the editor: Speech problems and speech delay: possible underdiagnosis of selective mutism

Chaya Rodrigues PEREİRA, Judith B. M. ENSİNK, Maretha V. de JONGE, Els WİPPO, Ram n J. L. LİNDAUER, Elisabeth M. W. J. UTENS

Ataxia, tremor, intellectual disability: a case of STXBP1 encephalopathy with a new mutation

Serdar Ceylaner, Aydan Değerliyurt, Gamze Gezgen Kesen

Early onset inflammatory bowel disease: manifestations, genetics and diagnosis

Bobak MOAZZAMİ, Kasra MOAZZAMİ, Nima REZAEI

Elemental mercury intoxication in 7 patients admitted to a pediatric rheumatology clinic

Betül Sözeri, Funda Baştuğ, Hülya Nalçacıoğlu, Hakan Poyrazoğlu, Ayşenur Paç Kısaarslan, Ruhan Düşünsel, Zübeyde Gündüz, Sibel Yel, Nihal Şahin, Sümeyra Özdemir Çiçek

Characteristics, diagnosis, and treatment modality of pediatric patients with cystic echinococcosis: a single centre experience

Ayşe KAMAN, Gönül TANIR, Emin ÇAKMAKÇI, Pervin DEMİR, Fatma Nur ÖZ, Türkan Aydın TEKE, Özge METİN, Zeynep Gökçe Gayretli AYDIN, Ayşe KARAMAN

Acute ophthalmoparesis and persistent mydriasis: expanding the clinical spectrum of anti-GQ1b positive cranial neuropathy in a 5.5-year-old girl

Ayfer Sakarya GÜNEŞ, Hülya Maraş GENÇ, Emek Uyur YALÇIN, Vuslat YILMAZ, Güher Saruhan DİRESKENELİ, Bülent KARA

Heart rate variability in juvenile systemic lupus erythematosus patients

Özge BAŞARAN, İbrahim İlker ÇETİN, Fatma AYDIN, Nermin UNCU, Nilgün ÇAKAR, Filiz EKİCİ, Banu Çelikel ACAR

A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation

Nurdan TAÇYILDIZ, Hikmet Gülşah TANYILDIZ, Emel ÜNAL, Handan DİNÇASLAN, Fikret ASARCIKLI, Başak Adaklı AKSOY, Göksel VATANSEVER, Gülsan YAVUZ

Familial reciprocal non robertsonian translocation t(14;22) resulting in 22q11.2 deletion syndrome

Nahla NAZMY, Ghada ELHADY, Esraa REFAAT, Soha KHOLEİF